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Abstract: This report describes the assessment of three specific
safety-related specifications in the consideration of an alter-
nate oxygenator; first the grip strength relationship between
various oxygenator connectors and SMARxT® tubing, second,
the grip strength of various biopassive tubings and an isolated
SMARxT® connector, and finally, the accuracy of the arterial
outlet temperature measurement. Grip strength experiments for
the connections between the SMARxT® tubing and the venous
reservoir outlet and the oxygenator venous inlet and oxygenator
arterial outlet of the Medtronic Affinity®, Sorin Synthesis®,
Sorin Primox®, and Terumo Capiox® RX25 oxygenators were
performed. In addition we compared the grip strength of poly-
vinyl chloride, Physio®, Trillium®, Carmeda®, X-Coating®, and
SMARxT® tubing. The accuracy of the integrated arterial outlet
temperature probes was determined by comparing the tempera-
tures measured by the integrated probe with a precision refer-
ence thermometer. Connector grip strength comparisons for the
evaluation oxygenators with SMARxT® tubing showed signifi-
cant variation between oxygenators and connections (p = .02).
Evaluation of the arterial outlet showed significant variation
between evaluation oxygenators, while at the venous reservoir
outlet and oxygenator inlet, there were no significant differ-
ences. Grip strength comparison data for the various tubing
types demonstrated a main effect for tubing type F(5, 18) =
8.01, p = .002, hp2 = .77. Temperature accuracy measurements
demonstrated that all oxygenators overread the arterial outlet
temperature at 15C, whilst at temperatures ³25C, all oxygena-
tors underread the arterial outlet temperature. The integrity of
SMARxT® tubing connection is influenced by the connector
type, and may decline over time, highlighting the importance to
not consider interchanging components of the bypass circuit as
inconsequential. Keywords: cardiopulmonary bypass, tubing,
temperature accuracy, rewarming, safety, cardiac surgery. JECT.
2012;44:53–59
The evaluation and selection of an oxygenator for clin-
ical use is an important process for the perfusionist in
the practice of cardiopulmonary bypass (CPB). Within the
products available there exists a spectrum of features that
may influence the assessment of a particular oxygenator
for routine clinical use, including gas transfer capability,
priming volume, membrane surface area, biocompatibil-
ity, heat exchanger performance, and blood flow dynam-
ics. Various sources of information are available when
evaluating alternative devices for this purpose, including
the manufacturer’s specifications and published, peer-
reviewed literature. Typically manufacturers focus on
physical (size, flow rate, etc) and performance-related
characteristics including gas transfer and heat exchanger
capabilities. Clinical studies will often focus on a narrow
spectrum of features of interest to the clinical group
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conducting the evaluation; these have recently included stud-
ies evaluating oxygen exchange (1–3), trans-oxygenator pres-
sure drop (1,3,4), heat exchanger performance (1), blood
trauma (1,2), and biocompatibility (5). Both clinical and
in vitro evaluations have comparatively assessed the air
separation performance of membrane oxygenators (6–9).
Two safety-related specifications of particular interest to our
group to evaluate when considering an alternate oxygenator
are the strength of the connections between the oxygenator
and the circuit tubing and the accuracy of the arterial temper-
aturemeasurement.
Newling and Morris (10) demonstrated a decrease in
tension required to disconnect SMARxT® tubing (Sorin,
Milano, Italy) compared to polyvinyl chloride (PVC) tub-
ing using an isolated tubing connector. However, a compar-
ative evaluation of the connections between SMARxT®
tubing with various oxygenator connectors has not been
reported, nor has a comparison using different types of
biopassive tubing. We previously reported on the integrity
of oxygenator-tubing connections prompted by two clinical
incidents in which disconnection of SMARxT® tubing
at the venous reservoir outlet of the Capiox SX25RX®
oxygenator (Terumo Corporation, Japan) occurred during
CPB (11). Investigation revealed that in the case of the
Capiox SX25RX® oxygenator, displacement of SMARxT®
tubing occurs over time when connected to the venous reser-
voir outlet connector. The integrity of this venous reservoir
outlet connector/tubing connection was influenced by the
physical characteristics of the connector, in particular
the relationship between the distances between barbs and
the width of the applied cable tie and the tapered nature
of the neck of the connector, leading to a decline in integrity
over time (11).
We have previously reported the accuracy of the oxy-
genator arterial temperature measurement used in our
routine practice (12), however limited data exist for com-
parison (13,14). The impact of hyperthermia on the brain
has been acknowledged as pivotal to any discussion on
the consequences of temperature management during
CPB; the pivotal factors involved include the rate of
rewarming and the temperature of the arterial blood
being delivered to the patient (12). Underreading of the
arterial outlet temperature at 37C has been previously
reported (12–14), therefore the evaluation of the accuracy
of this measurement prior to clinical use is important in
the context of avoidance of cerebral hyperthermia.
This report describes the assessment of three specific
safety-related specifications of interest to our group in the
consideration of an alternate oxygenator. First, we inves-
tigated the grip strength relationship between various
oxygenator connectors and SMARxT® tubing. Second, we
looked at grip strength of various biopassive tubings and
an isolated SMARxT® connector. Finally, we assessed the
accuracy of the arterial outlet temperature measurement.
METHODS
Four oxygenators from three manufacturers were cho-
sen to evaluate for routine use: Affinity® (Medtronic,
Minneapolis, MN), Synthesis® and Primox® (Sorin), and
the Capiox RX25® (Terumo Corporation).
Part A: Determination of a Baseline Criterion for
Grip Strength
To define a baseline grip strength, we measured the
change in the force required to disconnect SMARxT® tub-
ing from the venous outlet connector of the Capiox
SX25R03® oxygenator after 24 hours. This oxygenator was
chosen as we had used it routinely in over 6000 cases with-
out incident (11).A 10 cm length of SMARxT® 3/800 + 3/3200
tubing was pushed on to the maximal limit of the venous
reservoir connector for three separate Capiox SX25R03s®.
A 2.6 mm cable tie was positioned between the middle
barbs of the connector and secured with a Panduit GS2B
cable tie gun (Panduit Corporation, Tinley Park, IL) set at
tension position 8. The oxygenator reservoirs were secured
into a purpose built housing and secured into a vice
attached to the bed of an MDV4–5 milling machine
(Eumega, Hsin Chuang City, Taiwan) with adjustable height.
AMecmesin AFG1000N electronic force gauge (Mecmesin,
Slinfold, UK) was attached to the body of the milling
machine and set to record maximum force. A 6.1 mm
hole was drilled at 20 mm from the end of the tubing for
insertion of a hook attached to the force gauge, with vice
grip pliers securing the hook to the tubing to reduce
tearing. The height of the milling machine bed was
adjusted continuously via the electronic height adjust-
ment to create increasing force on the tubing. The height
adjustment was continued until tubing disconnection
occurred. To create the influence of weight over time the
process was repeated with a 500 g mass attached to the
end of the tubing for 24 hours prior to measurement of
the force required for disconnection. To allow quantifica-
tion and comparison with our previously reported inci-
dent (11), this method was repeated on the venous outlet
connector of the Capiox SX25RX® oxygenator.
Part B: Evaluation Oxygenator Connector
Physical Measurements
The physical characteristics of the arterial outlet, venous
inlet, and venous reservoir outlet connectors were mea-
sured in three of each evaluation oxygenator using a digi-
tal micrometer (Mitutoyo, Japan) to identify any variation
in barb diameter or overall length of the connectors.
Where the end of the connector was bevelled, the connec-
tor length was measured from the bottom of the neck to
the shortest part of the bevelled end. The first barb diam-
eter was measured as the external diameter of the barb
closest to the neck of the connector, and the second barb
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diameter, the external diameter of the barb closest to the
end of the connector.
Part C: Evaluation Oxygenator Connector Grip Strength
To measure the tubing/connector grip strength interac-
tion for the venous reservoir outlet, the oxygenator venous
inlet, and oxygenator arterial outlet in each of the evalua-
tion oxygenators, the experimental protocol in Part A was
repeated for each combination three times.
Part D: Comparison of Different Tubing Types
To compare the grip strength of different biopassive
tubings, we compared each against PVC tubing. Five dif-
ferent tubing typeswere evaluated: Physio® (Sorin,Milano,
Italy), Trillium® (Medtronic, Minneapolis, MN), Carmeda®
(Medtronic,Minneapolis,MN),X-Coating® (TerumoCorp.,
Tokyo, Japan), and SMARxT® tubing. A 10 cm length of
3/800 + 3/3200 PVC tubing (Sorin) was pushed on to themax-
imal limit of a 3/800–1/200 SMARxT® connector (Sorin). A
2.6mmcable tie positioned between themiddle barbs of the
connector was secured with a Panduit GS2B cable tie gun
set at tension position 8.A snug-fitted steel rodwas inserted
into the 1/200 end of the connectors, and secured into a vice
attached to the bed of the milling machine. A 6.1 mm hole
was drilled at 20mm from the end of the tubing for insertion
of a hook attached to the force gauge, with vice grip
pliers securing the hook to the tubing to reduce tearing.
The height of the milling machine bed was adjusted con-
tinuously via the electronic height adjustment to create
increasing force on the tubing. The height adjustment was
continued until tubing disconnection occurred. Measure-
ments were repeated three times using a new connector
and length of tubing.
Part E: Evaluation Oxygenator Arterial Temperature
Measurement Accuracy
To determine the accuracy of the arterial outlet temper-
ature measurement, experiments were performed in vitro.
Each experimental circuit consisted of an evaluation oxy-
genator and an arterial outlet line that connected to the
venous inlet of the reservoir. The line consisted of 80 cm of
SMARxT® tubing with an internal diameter of 3/800, a 3/8–
1/200 SMARxT® connector, and 20 cm of SMARxT® tubing
with an internal diameter of 1/200. After being CO2 flushed
for 3 minutes, circuits were primed and debubbled
according to the manufacturer’s instructions. The circuits
were primedwith expired donor blood anddilutedwith .9%
saline solution to a hematocrit of 21–24%. Flow through
the circuits was maintained at 4 L/min using a COBE roller
pump (COBECardiovascular, Arvada, CO)with appropri-
ate calibration and occlusion. Line pressurewasmaintained
at 150 ± 10 mmHg by the use of a gate clamp. Room air
gas flow through the test oxygenators was maintained at
500 mL/min. Oxygenator sampling manifolds remained
open, whilst the oxygenator purge lines were closed. Tem-
perature probe cables for each oxygenator were obtained
from the manufacturers. The accuracy of the integrated
arterial outlet temperature probes were determined by
comparing the temperatures measured by the integrated
probe and the temperature of the blood inside the tubing
adjacent to the probe. The temperature of the blood was
measured using an Instrulab 4601–40–01–03–07 precision
reference thermometer (Instrulab, Dayton, OH) inserted
into the tubing through a tightly fitted hole, as previously
reported (11). Calibration of the thermometerwas reported
as 99% occurrence of ±.05C (Commonwealth Scientific
and Industrial Research Organisation, Adelaide, Australia).
The tip of the reference probe was fully inserted and
directed across the internal diameter of the tubing to mini-
mize influence on the measurement as a result of immersion
stem effects or boundary layer effects. The blood tempera-
ture was regulated using a Hemotherm® (Cincinnati Sub-
Zero, Cincinnati, OH) heater cooler unit and recirculated
through the circuits at temperatures of 15, 20, 25, 30, 35, 37,
and 38C. Arterial outlet measurements were taken once the
target reference temperature was stabilized and maintained
for 3 minutes. Once the target temperature was obtained,
measurements were repeated three times at 1-minute inter-
vals using one of each of the test oxygenators. Experiments
were performed a total of three times using new oxygenators
and circuits.
STATISTICAL ANALYSIS
The general linear model was used for between group
comparisons while post-hoc tests specified Fisher’s Least
Significant Difference. Repeated measures data were ana-
lyzed by calculating a change score, that is, subtracting
Time 2 observations from Time 1 observations. In all anal-
yses p < .05was considered as statistically significant and no
adjustment was made for multiple comparisons. All data
were analyzed using SPSSV18.0.0 (SPSS Inc., Chicago, IL).
RESULTS
Part A: Quantification of a Baseline Criteria
The average grip strength of SMARxT® tubing connected
to the venous reservoir of the Capiox SX25R03® venous
reservoir outlet at initial connection was found to be 27.9 ±
1.6 kg. No decline over 24 hours was found (Table 1). A
14.3% decline was observed after 24 hours with the Capiox
SX25RX® (not significant).
Part B: Evaluation Oxygenator Connector
Physical Measurements
Measurements obtained of the connector physical
dimensions are shown in Table 2. All of the connectors
were found to have a tapered profile, as demonstrated
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by the average diameter of the second barb in relation
to the first. The Primox® and Synthesis® reservoir outlet
connectors had bevelled outlets. There was considerable
variation between the lengths of the connectors; however
we were unable to identify a particular oxygenator as con-
sistently different in its various connector lengths.
Part C: Evaluation Oxygenator Connector Grip Strength
Connector grip strength comparisons for the evaluation
oxygenators with SMARxT® tubing are summarized in
Table 3. SMARxT® tubing connected to the four test oxy-
genators showed significant variation in grip strength (p =
.02), with Affinity®, Capiox RX25®, and Primox® oxygen-
ators each demonstrating a decrease in grip strength on
average over 24 hours at each connection site.
Evaluation of the arterial outlet observations showed sig-
nificant differences between the different oxygenators, with
the Primox® and Affinity® demonstrating most change. At
the venous reservoir outlet and oxygenator venous inlet,
there were no significant differences between oxygenators.
Part D: Biopassive Tubing Grip Strength
Figure 1 summarizes the grip strength comparison data
for the various tubing types. There was a main effect for
tubing type F(5, 18) = 8.01, p = .002, hp2 = .77. Post-hoc tests
found that Trillium® had significantly greater grip strength
than PVC (p = .003), SMARxT® (p < .001), and Physio®
(p = .002). X-coating® also had significantly greater grip
strength than PVC (p = .031), SMARxT® (p = .001), and
Physio® (p = .022).
Part E: Evaluation Oxygenator Arterial Temperature
Measurement Accuracy
The average difference between arterial outlet and
reference thermometer temperatures are illustrated in
Figure 2. All oxygenators overread the arterial outlet tem-
perature at 15C. At 15C the Capiox RX25® oxygenator
arterial outlet temperature probe was found to have the
least accuracy (over reading .58 ± .02C). At temperatures
³25C, all oxygenators underread the arterial outlet tem-
perature. At 37C the Affinity® was found to underread
by .33 ± .03C, the Capiox® by .47 ± .06, the Primox® by
.61 ± .05, and the Synthesis® by .67 ± .09. Comparison
according to the accuracy of the arterial outlet temperatures
overall, found there was a significant between-oxygenator
difference F(3, 248) = 6.23,hp2 = .07, p < .001.
DISCUSSION
Three important clinical considerations are highlighted
in this report. First, connectors on the evaluation oxygen-
ators interact differently with SMARxT® tubing. Second,
different biopassive tubings interact differently with con-
nectors, and finally, none of the commercially available
devices we evaluated had accurate arterial outlet temper-
ature measurements. Each of these factors is clinically sig-
nificant when considering changes to hardware or arterial
outlet temperature management.
The variation we report in grip strength in relation to
both oxygenator connectors and various biopassive tubings
is important in the current environment where we are
being encouraged to tailor specific combinations of hard-
ware for individual patients, and where components of the
bypass circuit may be promoted to be relatively “plug and
play” in nature. We have shown this not to be the case,
demonstrating large variation between both different oxy-
genator connections and SMARxT® tubing and with dif-
ferent tubing types.
Our interest to address the safety concerns in relation
to connector grip strength and SMARxT® tubing arose
Table 1. Oxygenator connector grip strength.
Disconnection Weight (kg)
Oxygenator (n = 3) Tubing Type Time = 0 hours Time = 24 hours Percent Change
Baseline
Capiox SX25R03 SMARxT 27.9 ± 1.6 29.3 ± 3.4 5.0
Incident (13)
Capiox SX25RX SMARxT 27.5 ± 1.0 23.5 ± 2.4 –14.3
F(1, 4) = 5.79, p = .07, hp
2 = .59










Synthesis 12.0 ± 0 11.1 ± .01 18.1 ± .04
Affinity 12.2 ± .01 11.7 ± .01 19.1 ± .05
Capiox RX25 11.9 ± .02 11.4 ± .01 16.4 ± .09
Primox 12.0 ± .02 11.2 ± .02 18.1 ± .06
Oxygenator venous inlet
Synthesis 12.2 ± .02 11.3 ± .01 17.4 ± .09
Affinity 12.0 ± 0 11.6 ± .01 29.8 ± .17
Capiox RX25 12.5 ± .03 12.0 ± 0 23.2 ± .12
Primox 12.2 ± .01 11.3 ± .02 17.5 ± .03
Oxygenator arterial outlet
Synthesis 12.2 ± .02 11.9 ± .01 19.6 ± .04
Affinity 12.0 ± .01 11.6 ± 0 19.1 ± .07
Capiox RX25 12.5 ± .01 12.0 ± 0 24.6 ± .10
Primox 11.8 ± .02 11.6 ± .01 20.2 ± .01
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from disconnection incidents that occurred during CPB.
The root cause analysis investigation that followed these
incidents identified both the SMARxT® tubing and the
shape of the venous reservoir outlet connector on the
Terumo Capiox SX25RX® oxygenator as the major con-
tributors, resulting in degradation in integrity of the con-
nection over time. Hence, our objective in the evaluation of
an alternative oxygenator for routine use was to determine
whether a decrease in grip strength with the use of
SMARxT® tubing could be observed over time. A limiting
factor prior to undertaking this study was that the quantifi-
cation of a safe tubing connection strength in CPB circuits
has not been defined, therefore we examined as a baseline
the grip strength of the connection between SMARxT®
tubing and the venous reservoir outlet of the Capiox
SX25R03® oxygenator, a device which we had used without
incident for over 6000 cases. There was no decline in the
force required to achieve disconnection using SMARxT®
tubing and this outlet after 24 hours. There was a decline
after 24 hours with the Capiox SX25RX®; the difference
between devices was not found to be statistically signifi-
cant. Since our observations were limited to one time point
(24 hour), we are unable to report what may occur under
these conditions if they were extended. The decrease in grip
strength observed after 24 hours with the Capiox SX25RX®,
combined with the physical characteristics of the connector,
Table 3. Oxygenator connector grip strength – evaluation oxygenators.
Oxygenator (n = 3) Disconnection Weight (kg) Percent Change F(3, 8)* p hp
2
Venous reservoir outlet Time = 0 hours Time = 24 hours 3.38 .08 .56
Affinity 33.8 ± 4.5 28.4 ± 4.2 –15.9
Capiox RX25 31.9 ± 2.3 27.5 ± 1.9 –14.1
Primox 22.6 ± 2.3 21.5 ± .8 –4.9
Synthesis 24.2 ± 1.6 24.4 ± .2 1.0
Oxygenator venous inlet 1.17 .38 .31
Affinity 33.2 ± 3.3 31.1 ± .5 –6.3
Capiox RX25 31.2 ± 7.0 30.6 ± 4.1 –1.9
Primox 22.8 ± 4.2 22.3 ± 7.6 –2.2
Synthesis 11.7 ± 1.3 18.6 ± 1.9 58.7
Oxygenator arterial outlet 4.74 .04 .64
Affinity 37.6 ± 1.7 32.7 ± 2.5 –13.2
Capiox RX25 42.2 ± 3.8 41.3 ± 2.1 –2.1
Primox 40.9 ± 6.4 27.9 ± 2.9 –32.0
Synthesis 33.7 ± 7.9 36.8 ± 2.0 9.2
Overall 3.87 .02 .27
*DF = (3, 32) for overall comparisons.
Figure 1. Disconnection weight measurements for different biopassive tub-
ing types. There was a main effect for tubing type (F(5, 18) = 8.01, p = .002,
hp
2 = .77); Trillium®, and X-coating® were significantly greater than PVC,
SMARxT®, and Physio®.
Figure 2. Accuracy of the arterial outlet blood temperature measurement
for each of the evaluation oxygenators at temperatures between 15C
and 38C. Values >0 indicate overreading, values <0 indicate under-
reading. All oxygenators underread the arterial temperature at 37C.
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in particular the taper, supports the root cause for the
disconnection previously reported (11).
Our grip strength findings for the evaluation oxygenators
indicate that overall for the group there was not a significant
change after 24 hours using SMARxT tubing on the venous
reservoir and venous inlet connectors, however there was
significant change after 24 hours using SMARxT tubing on
the arterial outlet connectors. These results suggest that in
respect to safety, clinicians should be aware that the strength
of all connections will vary when a new device is used. It is
not possible for us to make a clear safety recommendation
with respect to the magnitude of the reported grip strength.
Our baseline values of 27.9 ± 1.6 at time 0 and 29.3 ± 3.4 at
24 hours provide some guidance for our own clinical envi-
ronment, however we cannot relate this absolute value to a
safe value for any given clinical situation.
We found no major variation in the barb diameters of the
connectors between the different oxygenators. We did find
variations in the length of the different connectors, although
we were unable to identify a particular connector as an obvi-
ous safety concern given the overall dimensions and taper.
An important finding with respect to the different
biopasssive tubing types was that overall there was a signifi-
cant difference between the different types of biopassive
tubing, suggesting that it is not reasonable to assume that
interchanging different types of tubing into a clinical circuit
is inconsequential. In our comparison only SMARxT® tub-
ing had a grip strength less than PVC, however this differ-
ence was not statistically significant. We observed only a
7.4% decrease in grip strength with the use of SMARxT®
tubing versus PVC, comparedwith a 28%decrease reported
by Newling andMorris (10). This is likely to be attributed to
differences in experimental method, in particular the tubing
was positioned just after the first barb on the connector and
a cable tie was not reported to be applied in the Newling
and Morris technique, possibly explaining the differences
in the amount of force required to dislodge the tubing
between the studies (83.3 ± 7.3 N (Newling and Morris)
compared with 368.7 ± 27.4 N (37.6 ± 1.9 kg) in our study).
In terms of clinical outcomes for our patients, potentially
our most important finding is reporting the inaccuracy of
the arterial outlet temperature measurements of all the
oxygenators that we studied. The temperature measure-
ments of all oxygenators overread at 15C and underread
at temperatures ³25C. These results are similar to those
observed by Salah et al. (13) and Potger andMcMillan (14),
and to what we have found previously with the Capiox
SX25® oxygenator (12). The rationale of avoiding cerebral
hyperthermia has been summarized by Shann et al. (15),
and in the recommendation made by those authors they
added a caveat that “Coupled temperature ports for all oxy-
genators should be checked for accuracy and calibrated”.
Our findings reinforce the need to continue this practice.
Despite this recommendation and the ongoing interest in
arterial outlet temperature measurement, manufacturers
have not been able to provide clinicians with an accurate
temperature measurement. To avoid exceeding an arterial
blood temperature of 37C the maximum arterial outlet
temperature should vary depending on the oxygenator
being used. From our study to maintain an arterial outlet
temperature <37C a target temperature of <36.7C should
be targeted with the Affinity®, <36.5C with the Capiox
RX25®, <36.4C with the Primox®, and <36.3C with the
Synthesis® oxygenator.
LIMITATIONS
This report must be considered in light of its in vitro
nature and the implicit limitations imposed by this design.
Since the report is focused on the devices in consideration
by our unit, further investigations of other devices are
warranted, particularly in regard to the evaluation of arte-
rial outlet temperature measurement accuracy. The results
from the grip strength comparisons are limited by the vari-
ation observed in repeated measures; therefore we have
focused our assessment to whether a decline over time
was observed as opposed to relative comparisons between
devices. The variation in measurements of grip strength
under experimental conditions based on consistency of
connection and securing of the tubing to the connector,
and the method of measuring the force required for discon-
nection highlight the importance of maintaining consis-
tency in making circuit connections in clinical practice.
Standardization of connection technique and checking of
the visual assessment of the integrity of connections prior
to the initiation of CPB, through inclusion on the pre-CPB
checklist, may be important (11).
CONCLUSIONS
The integrity of SMARxT® tubing connection is influenced
by theconnector type, andmaydeclineover time, highlighting
the importance to not consider interchanging components of
the bypass circuit as inconsequential. All of the oxygenators
temperature measurement overread at 15C and underread
at temperatures ³25C, demonstrating the need for clinicians
to recognize the variation between devices.
REFERENCES
1. Segers P, Heida JF, de Vries I, Maas C, Boogaart AJ, Eilander S.
Clinical evaluation of nine hollow-fibre membrane oxygenators. Per-
fusion. 2001;16:95–106.
2. ChukwuemekaAO, TurtleMRJ, Trivedi UH, VennGE, Chambers DJ.
A clinical evaluation of platelet function, haemolysis and oxygen
transfer during cardiopulmonary bypass comparing the Quantum
HF-6700 to the HF-5700 hollow fibre membrane oxygenator. Per-
fusion. 2000;15:479–84.
JECT. 2012;44:53–59
58 R.F. NEWLAND ET AL.
3. Noora J, Lamy A, Smith KM, et al. The effect of oxygenator mem-
branes on blood: A comparison of two oxygenators in open-heart
surgery. Perfusion. 2003;18:313–20.
4. Ündar A, Owens WR, McGarry MC, et al. Comparison of hollow-
fiber membrane oxygenators in terms of pressure drop of the mem-
branes during normothermic and hypothermic cardiopulmonary bypass
in neonates. Perfusion. 2005;20:135–8.
5. Hoel TN, VidemV, Baksaas ST,Mollnes TE, Brosstad F, Svennevig JL.
Comparison of a Duraflo II-coated cardiopulmonary bypass circuit
and a trillium-coated oxygenator during open-heart surgery. Perfusion.
2004;19:177–84.
6. DickinsonTA,Riley JB,Crowley JC,Zabetakis PM. In vitro evaluation
of the air separation ability of four cardiovascular manufacturer extra-
corporeal circuit designs. J Extra Corpor Technol. 2006;38:206–13.
7. Myers GJ, Voorhees C, Haynes R, Eke B. Post-arterial filter gaseous
microemboli activity of five integral cardiotomy reservoirs during
venting: An in vitro study. J Extra Corpor Technol. 2009;41:20–7.
8. Preston TJ, Gomez D, Olshove VF, Phillips A, Galantowicz M. Clin-
ical gaseous microemboli assessment of an oxygenator with integral
arterial filter in the pediatric population. J Extra Corpor Technol.
2009;41:226–30.
9. Liu S, NewlandRF, Tully PJ, Tuble SC, Baker RA. In vitro evaluation
of gaseous microemboli handling of cardiopulmonary bypass circuits
with and without integrated arterial line filters. J Extra Corpor
Technol. 2011;43:107–14.
10. Newling R, Morris R. SMARxT tubing presents an increased risk
of disconnection during extracorporeal circulation. J Extra Corpor
Technol. 2005;37:400–1.
11. Ottens J, Baker RA, Sanderson AJ, Newland RF. Disconnection
of Cobe SMARxT® tubing from the venous outlet of the Terumo
Capiox® SX25RX oxygenator during cardiopulmonary bypass. J Extra
Corpor Technol. 2010;42:153–7.
12. Newland RF, Sanderson AJ, Baker RA. Accuracy of temperature
measurement in the cardiopulmonary bypass circuit. J Extra Corpor
Technol. 2005;37:32–7.
13. Salah M, Sutton R, Tsarovsky G, Djuric M. Temperature inaccu-
racies during cardiopulmonary bypass. J Extra Corpor Technol.
2005;37:38–42.
14. Potger KC, McMillan D. In vitro validation of the Affinity NT
oxygenator arterial outlet temperatures. J Extra Corpor Technol.
2005;37:207–12.
15. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based
review of the practice of cardiopulmonary bypass in adults: A focus
on neurologic injury, glycemic control, hemodilution, and the
inflammatory response. J Thorac Cardiovasc Surg. 2006;132:
283–90.
JECT. 2012;44:53–59
OXYGENATOR SAFETY EVALUATION 59
